BERTOLOTTI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 26.548
AS - Asia 12.880
EU - Europa 12.261
SA - Sud America 1.753
AF - Africa 250
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 16
Totale 53.740
Nazione #
US - Stati Uniti d'America 26.062
SG - Singapore 4.110
CN - Cina 3.470
IT - Italia 3.464
GB - Regno Unito 3.129
HK - Hong Kong 1.565
BR - Brasile 1.306
VN - Vietnam 1.230
DE - Germania 1.030
SE - Svezia 955
FI - Finlandia 783
UA - Ucraina 587
BD - Bangladesh 554
FR - Francia 533
TR - Turchia 482
RU - Federazione Russa 462
PL - Polonia 386
KR - Corea 328
CA - Canada 309
IN - India 244
BG - Bulgaria 228
NL - Olanda 204
ID - Indonesia 168
AR - Argentina 165
IQ - Iraq 104
JP - Giappone 100
MX - Messico 92
ES - Italia 83
IE - Irlanda 73
EC - Ecuador 66
ZA - Sudafrica 59
PK - Pakistan 58
AE - Emirati Arabi Uniti 53
BE - Belgio 53
VE - Venezuela 53
AT - Austria 51
MA - Marocco 50
CL - Cile 45
CO - Colombia 45
MY - Malesia 45
PH - Filippine 44
UZ - Uzbekistan 43
TW - Taiwan 39
SA - Arabia Saudita 36
CH - Svizzera 34
CZ - Repubblica Ceca 32
IR - Iran 29
AU - Australia 26
JO - Giordania 25
LT - Lituania 25
PE - Perù 25
ET - Etiopia 24
TH - Thailandia 24
EG - Egitto 23
PY - Paraguay 21
DZ - Algeria 19
RO - Romania 19
TN - Tunisia 19
CR - Costa Rica 18
GR - Grecia 17
KE - Kenya 16
UY - Uruguay 16
NP - Nepal 15
OM - Oman 15
TT - Trinidad e Tobago 13
AZ - Azerbaigian 11
BY - Bielorussia 11
IL - Israele 11
PA - Panama 11
PT - Portogallo 11
SI - Slovenia 11
BO - Bolivia 10
MK - Macedonia 9
NG - Nigeria 9
RS - Serbia 9
DO - Repubblica Dominicana 8
EU - Europa 8
JM - Giamaica 8
SY - Repubblica araba siriana 8
AL - Albania 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LU - Lussemburgo 7
MD - Moldavia 7
NI - Nicaragua 7
PS - Palestinian Territory 7
SK - Slovacchia (Repubblica Slovacca) 7
BH - Bahrain 6
DK - Danimarca 6
HN - Honduras 6
HU - Ungheria 6
KW - Kuwait 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
SN - Senegal 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
CY - Cipro 5
GT - Guatemala 5
LB - Libano 5
Totale 53.665
Città #
Singapore 2.776
Santa Clara 2.421
Fairfield 2.378
Ashburn 2.306
Southend 2.013
Hong Kong 1.543
Woodbridge 1.496
Chandler 1.322
Houston 1.313
Jacksonville 1.044
Hefei 984
San Jose 903
Seattle 890
Dearborn 830
Wilmington 824
Ann Arbor 820
Cambridge 787
Beijing 631
Helsinki 577
London 572
Nyköping 571
Chicago 560
Los Angeles 508
Ho Chi Minh City 404
Modena 384
Warsaw 370
New York 322
Seoul 315
The Dalles 304
Council Bluffs 297
San Diego 296
Milan 293
Hanoi 280
Izmir 278
Princeton 242
Sofia 216
Salt Lake City 197
Eugene 187
Lauterbourg 186
Buffalo 161
Shanghai 161
Rome 153
Moscow 143
Munich 131
São Paulo 125
Tampa 117
Dallas 115
Elk Grove Village 111
Toronto 109
Des Moines 107
Bologna 104
Jakarta 104
Fremont 83
Boardman 81
Orem 78
Tokyo 78
Frankfurt am Main 75
Redwood City 75
Guangzhou 71
Columbus 67
Dublin 62
Haiphong 62
Bremen 57
Grafing 57
Da Nang 55
Falls Church 54
Sterling 53
Brooklyn 52
Phoenix 50
Baghdad 49
Montreal 48
Naples 46
Brussels 44
Florence 44
Parma 43
Denver 40
Turku 40
Lancaster 39
North York 39
San Mateo 39
Nuremberg 38
Turin 38
Amsterdam 36
Atlanta 35
Mountain View 35
Kunming 34
Miami 34
Tashkent 34
Chennai 33
Norwalk 33
Kent 32
Nanjing 32
Padova 32
San Francisco 32
Manchester 31
Mexico City 30
Boston 28
Rio de Janeiro 27
Verona 27
Zhengzhou 27
Totale 36.510
Nome #
MoCA 7.1: Multicenter Validation of the First Italian Version of Montreal Cognitive Assessment 1.057
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 709
17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures 467
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 451
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 446
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 430
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 424
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 416
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 409
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 406
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 401
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 382
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 377
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 377
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 376
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 374
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 370
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 370
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 369
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 369
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 364
Serum time course of naltrexone and 6 beta-naltrexol levels during long term treatment in drug addicts 363
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 361
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 360
Physical exercise for late life depression: effects on cognition and disability 359
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 355
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 351
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 347
Telomere length elongation after weight loss intervention in obese adults 344
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 342
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 340
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 338
Endocrine and liver interaction: the role of endocrine pathways in NASH 338
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 337
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 334
Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report 330
Analgesic drug taking: Beliefs and behavior among headache patients 329
Effects of cholecalciferol supplementation in patients with stable heart failure and low vitamin D levels (ECSPLOIT-D). A double-blind, randomized, placebo-controlled pilot study 327
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study 324
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 324
The relationship between age and fat infiltration in liver and muscle 324
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 323
Bile acids and nonalcoholic fatty liver disease: An intriguing relationship 320
Nonalcoholic fatty liver disease and aging: epidemiology to management 319
La clinica metabolica per il trattamento della lipodistrofia 318
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 313
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e 310
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 309
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 307
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 305
Risk of birth defects associated with maternal pregestational diabetes. 302
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 301
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 298
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 298
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 293
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 292
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 292
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 288
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 287
Advances in the comprehension of the pathophysiology of bile secretion 286
Predictive factors of lack of response to antiviral therapy among in patients with recurrent hepatitis C after liver transplantation. 286
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 284
Effects of acute changes of bile acid pool composition on biliary lipid secretion 282
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 282
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials 282
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 280
Olanzapine metabolic side effects: a weight gain issue? 280
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 276
Liver X receptors and copper metabolism: New frontiers for the oxysterol receptors 275
Anatomia e fisiologia delle vie biliari 270
Disposition of naproxen after oral administration during and between migraine attacks. 270
Review article: effect of bile salt pool composition on hepatic and biliary functions 270
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 268
Bile acid structure and regulation of biliary protein secretion and composition in man 267
Case of an old man with aortic dissection type A and enlarging meningioma 267
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention 267
Effect of ursocholic acid on bile lipid secretion and composition 263
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 261
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 260
The use of stable and radioactive sterol tracers as a tool to investigate cholesterol degradation to bile acids in humans in vivo 259
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 259
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 258
Review article: hyperlipidaemia and cardiovascular risk 256
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 256
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 255
Hypertensive disease in the elderly: Predictors of clinical evolution in a follow-up study 252
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 251
Nonalcoholic fatty liver disease induced by leuprorelin acetate 251
REGULATION OF HEPATIC CHOLESTEROL-METABOLISM IN THE RAT IN-VIVO. EFFECT OF A SYNTHETIC FAT-FREE DIET ON STEROL SYNTHESIS AND LOW-DENSITY-LIPOPROTEIN TRANSPORT 250
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 250
Drug-Induced Liver Injury - Types and Phenotypes 249
PHARMACOKINETICS OF TIAPROFENIC ACID AFTER ORAL-ADMINISTRATION IN FASTING PATIENTS DURING AND BETWEEN MIGRAINE ATTACKS 246
Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy 246
Risk communication at the time of Coronavirus: are we washing our hand of COVID-19? 245
Influence of age and sex on serum concentrations of total dimeric activin A 244
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 244
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018] 241
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 241
Associated factors to post-operative delirium in patients with hip fractures: an orthogeriatric experience. 240
Heart failure and chronic kidney disease in a registry of internal medicine wards 240
Totale 32.355
Categoria #
all - tutte 206.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 206.807


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021194 0 0 0 0 0 0 0 0 0 0 0 194
2021/20224.377 183 479 311 389 101 218 314 266 552 243 808 513
2022/20233.991 417 361 312 350 448 576 102 430 510 74 218 193
2023/20242.853 128 163 184 271 527 231 366 339 103 111 135 295
2024/20258.969 320 152 215 638 1.816 1.277 587 444 876 449 972 1.223
2025/202618.235 996 697 1.426 2.152 3.209 1.669 1.946 842 1.671 1.423 1.316 888
Totale 54.065